Research & development

Scientific advances boost anti-doping campaign

08 February, 2006 by Peter Brownlee

The unprecedented anti-doping campaign for the 2006 Commonwealth Games in Melbourne is aimed at making these Games the cleanest ever with thousands of tests being carried out on athletes in Australia and overseas

Tracking performance in real time

07 February, 2006

Traqua, developed by the CRC for microTechnology for the Australian Institute of Sport (AIS), is the leading edge of the next sports revolution - providing hard data in real time on an athlete's motion to reinforce the coach's eye and instincts.

How viruses enter cells

07 February, 2006

A team of Northwestern University researchers has solved the structure of a molecule that controls the ability of viruses of the paramyxovirus family, including the viruses that cause measles, mumps, and many human respiratory diseases, to fuse with and infect human cells.

Neutron scattering and cell signalling

06 February, 2006

Neutron scattering research techniques that can show how nature uses complex protein structures to get cells to respond and adapt to stimuli in the body, could be the new tool to help researchers find new drugs to treat diseases such as heart failure or cancer. Dr Jill Trewhella, a joint ANSTO and Sydney University Research Fellow, is an expert in using neutron scattering to study cell signalling systems which regulate the body.

Monitoring of living cells

06 February, 2006

Cell cultures often form the testing ground for new active agents. Results can only be reliable if cell growth is standardised. This process will soon happen automatically with a microscope to monitor growth and image processing to control cultivation via integrated robotics.

Protein improves body's fight

01 February, 2006

Monash University scientists have discovered how a single protein could dramatically improve the body's ability to fight viruses such as the flu.

HLS5 Gene implicated in Huntington's

30 January, 2006

The Western Australian Institute for Medical Research (WAIMR) has discovered a link between the HLS5 gene and key aspects of Huntington’s disease and AIDS development, according to an announcement made by BioPharmica.

Natural chemistry finds it way to market

20 January, 2006

Faster reaction rates, a substantially higher yield and a cleaner production process than is currently possible in the chemical industry, is claimed to be the result of a new sustainable chemical process that researchers from the Universiteit van Amsterdam and Radboud Universiteit Nijmegen have developed with support from NWO ACTS (Advanced Chemical Technologies for Sustainability).

Curry could halt prostate cancer

17 January, 2006

Rutgers, the state university of New Jersey, USA, researchers have found that the curry spice turmeric holds real potential for the treatment and prevention of prostate cancer, particularly when combined with certain vegetables.

Trials in measuring radiation doses accurately

12 January, 2006

Researchers have begun trials which will allow radiation doses in computed tomography (CT) scans to be estimated much more accurately.

Gene patent study misleading

06 January, 2006

A report in Science journal relating to gene patenting claimed: "Nearly a fifth of all human genes have been patented, a study has found, leading to fears that research into diseases such as breast cancer, diabetes and obesity could be stifled."

CRC discovery contributes to asthma drug development

16 December, 2005

A discovery made at WEHI by the Cooperative Research Centre for Cellular Growth Factors (CRC-CGF) has led to the selection of an antibody-based drug for full preclinical development as a potential new treatment for asthma and other respiratory diseases.

Study suggests drug may reverse psychosis

01 December, 2005

Cannabis, a drug believed to increase the risk of psychosis in users, contains a compound that may be able to reverse psychotic behaviour, Monash researchers have found.

Collaborators seek parasite invasion blockers

18 November, 2005

A malaria research team, including WEHI Structural Biologist, Professor Ray Norton, has received a US$1 million grant from the US National Institutes of Health to develop more effective malaria treatments.

Method to detect potential bioterrorism agent

08 November, 2005

A new combination of analytical chemistry and mathematical data analysis techniques allows the rapid identification of the species, strain and infectious phase of the potential biological terrorism agent Coxiella burnetii. The bacterium causes the human disease Q fever, which can cause serious illness and even death.

  • All content Copyright © 2019 Westwick-Farrow Pty Ltd